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Edited by Lukas HuberAbstract PaAMP is a small seed-speciﬁc antimicrobial protein
from pokeweeds. It has a cysteine-knot fold with a positive patch
and a hydrophobic surface. Site-speciﬁc mutagenesis was per-
formed to study the roles of these two domains in antimicrobial
activity and we found that the mutations in the hydrophobic sur-
face had a more profound eﬀect than that in the positive patch. A
protein–membrane interaction was observed with the green ﬂuo-
rescence protein–PaAMP (GFP–AMP) fusion protein. The
mutations that replace the amino acid residues forming hydro-
phobic surface with neutral residues abolished the interaction
of PaAMP with the membrane and the binding of PaAMP to
fungal sphingolipids while ergosterol enhanced the binding, sug-
gesting that the hydrophobic surface was required for the inter-
action between PaAMP and fungal plasma membrane lipid raft.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Seed germination period in plant life cycle is probably most
vulnerable time to microbial attacks because the rapture of
seed coat would allow pathogen invasion into the storage tis-
sue. It is thus not surprising that plant seeds produce a variety
of antimicrobial proteins and peptides such as the plant defen-
sins that have been isolated from seeds of many plants [1,2].
Another kind of antimicrobial protein has been reported in
Mirabilis jalapa (MjAMP) and Phytolacca americana
(PaAMP) [3–7]. PaAMP from pokeweeds is seed-speciﬁc and
it is released from the germinating seeds to create an inhibitory
zone against pathogens [5]. However, the mechanism of
PaAMP against microorganisms is not understood at the
moment.
The biochemical basis for the inhibition of yeast cells by the
plant defensin DmAMP from Dahlia merckii has been studied
and it is shown that sphingolipids are involved in DmAMP
binding to the yeast plasma membranes [8,9]. The interaction
between DmAMP and the yeast membrane could probably oc-
cur directly without the involvement of membrane proteins
[9,10] and it probably leads to an insertion of the defensin into*Corresponding author. Fax: +86 10 6275 1526.
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doi:10.1016/j.febslet.2005.03.046the membrane, resulting in an alteration of the membrane
property and inhibition of fungal growth [11].
The structure of the PaAMP protein determined by NMR
[12] has cysteine-knot folding with anti-parallel b-sheets stabi-
lized by three disulﬁde bridges and it has a positive patch and a
hydrophobic surface [5,12]. The two structural domains are so
arranged to each other that the protein is strongly amphi-
pathic. This feature of PaAMP is found in many antimicrobial
proteins and it provides a hint that it might be involved in pro-
tein–membrane interaction. To study the mechanism of
PaAMP against microorganisms and to understand the two
domains in antimicrobial activity, site-speciﬁc mutagenesis
was performed to speciﬁcally replace the residues in those
two domains with neutral residues. We also constructed green
ﬂuorescence protein (GFP)–PaAMP fusion protein to locate
the interaction site of the protein with fungal cells.2. Materials and methods
2.1. Strains, Plasmids and site-speciﬁc mutagenesis
The Escherichia coli strain DH5a was used for all routine cloning
purpose and the strain BL21(DE3)/pLysS was used for overproduction
of recombinant proteins. The fungi Fusarium solani and Neurospora
crassa were grown in YPG (0.3% yeast extract, 1% peptone, 2% glu-
cose [pH 4.5]) medium at 30 C.
The plasmids for overproduction of diﬀerent PaAMP fusion pro-
teins in E. coli were constructed as follows. The PaAMP gene was
ampliﬁed by PCR with primers TTCCATGGCGGGATGCATAAA-
GAATGGGGG and TAATATAGTATGGGATCCTATCCCC using
PaAMP cDNA as template. The ampliﬁed fragment was digested with
NcoI and BamHI and ligated into pET-30 to generate the plasmid pE-
T30AMP for production of His-tagged PaAMP. To construct a plas-
mid overproducing GFP–PaAMP fusion protein, the PaAMP gene
was ampliﬁed by PCR as above. The ampliﬁed fragment was digested
with NcoI and BamHI and ligated into pET-3d to generate the plasmid
p3d-AMP. The modiﬁed GFP gene was ampliﬁed by PCR with
the primers GGATCCATGGTGAGCAAGGGCGAGGAG and
TTTGCCATGGCCTTGTACAGCTCGTCC using the plasmid
pCOP1-GFP [13] as template. The ampliﬁed fragment was digested
with NcoI before insertion into the NcoI site of p3d-AMP to generate
the plasmid p3dGFP–AMP for overexpression of the translational fu-
sion GFP–PaAMP gene. The construction of the PaAMP–GFP fusion
gene and its overexpression will be described elsewhere.
Site-speciﬁc mutagenesis of the PaAMP gene was performed using
the mutagenesis kit from Promega as described previously [14]. The
following mutations were introduced into the PaAMP gene: K5A,
N6R, F25A, I27A, V34A, K36E, R38N and I27A–V34A. These mu-
tant genes were generated with primers: TACGGATCCGCGG-
GATGCATAGCGAATGG, TACGGATCCGCGGGATGCATAA-
AGAGAGG, TACGGATCCGCGGGATGCATAAAGGCAGG,
ATTTGCGCGCAATAGCTAGAACAACAGTATG, ACACCATA-
GGATTGGCCGGCCGCTTGGAAACA, TAGGATTGTCCAG-blished by Elsevier B.V. All rights reserved.
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CAC, and TAAGAATTCTCAGCGGTTTTCGCAAACAC, respec-
tively. The mutant genes were conﬁrmed by DNA sequencing.
Overproduction of PaAMP and its derivatives were performed as
described [15].
2.2. Protein puriﬁcation
For puriﬁcation of the His-tagged PaAMP overproduced in E. coli,
the cell extracts were centrifuged at 30 000 · g for 40 min at 4 C and
the pellet was discarded. The PaAMP with His-tag was adsorbed to a
Ni-chelating column (1.0 · 2.5 cm). The column was washed three
times with phosphate butter before enterokinase was added to the col-
umn for cleavage of the fusion His-tagged PaAMP protein. The
cleaved PaAMP was eluted from the column with the phosphate buﬀer
and concentrated by ultraﬁltration. For puriﬁcation of both GFP–
PaAMP and PaAMP–GFP fusion proteins, the cell extracts were cen-
trifuged as above. To the supernatant, ammonium sulfate was added
to a saturation of 60% and the solution was centrifuged again. The pel-
let containing the fusion proteins was resuspended in buﬀer A contain-
ing 20 mM HEPES (pH 7.0) and 10% ammonium sulfate was loaded
onto a phenyl-Sepharose CL-4B (Amersham Pharmacia Biotech) col-
umn which has been equilibrated with buﬀer A. The fusion proteins
were eluted with a gradient of ammonium sulfate from 10% to 0%
and both fusion proteins were eluted nearly at the end of the gradient.
The fusion proteins were further puriﬁed with a Sephadex G-50 ﬁltra-
tion column (2.5 · 35 cm) and eluted with buﬀer A without ammonium
sulfate at a ﬂow rate of 15 mL h1.
2.3. Antimicrobial activity assays
The minimal inhibitory concentration of the proteins was deter-
mined according to Wu and Hancock [16]. Serial 2-fold dilutions of
proteins were made in 20 mM Tris–HCl (pH 7.4) in a 96-well microti-
ter plate before mixing with 50 ll YPG broth in each well. To each
well, 50 ll of YPG containing about 2 · 104 spores mL1 were added.
The plate was incubated at 25 C for 48 h. The germination and
growth of the spores were determined by measuring the culture absor-
bance at 595 nm using a microtiter plate reader (Bio-rad). The protein
concentrations required for 50% growth inhibition (IC50) after 48 h
incubation were determined by plotting the growth inhibition versus
protein concentrations [3]. A speciﬁc antimicrobial activity was deﬁned
as 1/IC50, and a relative activity of a protein was expressed as described
by De Samblanx et al. [17]. For microscopic observation of the inhibi-
tion of spore germination or hypha growth of F. solani, the fungal
spores or hyphae in 1 mL YPG containing PaAMP protein or its deriv-
atives were incubated for 16 h at 25 C with gentle shaking.
2.4. Other methods
Isolation of N. crassa sphingolipids and binding of PaAMP proteins
to the sphingolipids were performed according to Thevissen et al. [10].
Protein concentration was determined by Lowry method [18]. Free cys-
teine thiol groups were determined by the Ellman assay on both re-
duced and unreduced proteins as described [19]. We found that less
than 3% of the cysteine residues of the produced PaAMP proteins were
in free cysteine form.3. Results
3.1. The mutant PaAMP proteins and their antimicrobial
activities
To study functions of individual amino acid residues of
PaAMP by site-speciﬁc mutagenesis, it is necessary to isolate
the protein in relatively large amount and to measure the activ-
ity of the mutant protein quickly. We thus established an over-
expression system for PaAMP. We overproduced PaAMP as a
fusion protein in E. coli and found that the fusion protein sys-
tem of pET-30 was suitable for the purpose (Fig. 1). The fusion
protein was produced in soluble form and we puriﬁed it with a
metal aﬃnity column. The puriﬁed fusion protein was then
treated with enterokinase to remove the N-terminal part ofthe fusion protein. The expression system was also used to
overproduce the mutant proteins of PaAMP constructed
through site-speciﬁc mutagenesis (Table 1). We also con-
structed fusion genes encoding GFP–PaAMP, PaAMP–GFP
and GFP–PaAMPI26A–V34A fusion protein. The overproduced
fusion proteins were puriﬁed and analysed with SDS–PAGE
(Fig. 1B).
The activity of rPaAMP against fungus F. solani was nearly
identical to that of the PaAMP isolated from pokeweed seeds
(Fig. 2A). The IC50 for PaAMP isolated from pokeweed seeds
and rPaAMP against F. solani growth were 1.30 and 1.36 lM,
respectively. This result suggests that the structure of rPaAMP
is nearly identical to that of PaAMP present in pokeweed
seeds. Fig. 2A also showed the inhibitory eﬀects of both
GFP–AMP and AMP–GFP. The values of IC50 and the rela-
tive activities of all rPaAMP proteins were summarized in
Table 1.
The results of side-speciﬁc mutagenesis show that both the
positive patch (including residues K36, R38 and K5) and the
hydrophobic surface (including residues I27, F25 and V34)
are important to the function of PaAMP. The K36A and
R38A mutations resulted in a moderate 25% and 27% reduc-
tion of the antimicrobial activities, respectively (Table 1). A
more profound eﬀect was observed with PaAMPK5A, which
led to a 48% reduction of the antimicrobial activity. A sim-
ilar result was reported for the defensin from radish seeds
[17]. The mutation of N37R in PaAMP, which was con-
structed to increase the antimicrobial activity as in case of
the V39R mutation of the radish defensin [17], reduced the
activity by 50%.
Compared with the mutations in positive patch, all muta-
tions in the hydrophobic surface had a more profound eﬀect
on the antimicrobial activity of PaAMP. The I27A, F25A
and V34A mutations led to 72%, 81% and 82% reduction
of the antimicrobial activity, respectively. The double muta-
tion I27A–V34A led to a nearly complete loss of the antimi-
crobial activity. These results suggest that the hydrophobic
surface of PaAMP is critical to the antimicrobial function
of the protein.
PaAMP is inhibitory to the growth of another fungus
N. crassa and the eﬀects of mutations in both hydrophobic
surface and positive domain were similar to that observed
in F. solani (Fig. 2B). The values of IC50 for rPaAMP and
PaAMPK5A on N. crassa were 1.93 and 4.59 lM, respectively.
The PaAMP with double mutation of I27A and V34A
(PaAMPI–V) completely lost the antimicrobial activity against
N. crassa.
3.2. Interaction of PaAMP with fungal membranes
The PaAMP–GFP fusion proteins are inhibitory to the
growth F. solani and their activities were comparable to that
of the rPaAMP (Table 1). Since GFP fusion protein could
be observed with a ﬂuorescence microscope, we used
GFP–PaAMP fusion protein to localize the interaction site
of PaAMP and the results are shown in Fig. 3. Addition
of GFP–PaAMP fusion protein to the spore suspension at
a concentration of 5 lM led to a complete inhibition of
spore germination (Fig. 3A). Occasionally, binding of
GFP–PaAMP to released protoplasm was observed (Fig.
3A2). Addition of GFP did not lead to any inhibition of
the germination of the spores (Fig. 3B). No ﬂuorescence
could be observed from the germinating spores with GFP
Table 1
The values of IC50 and relative activities of the recombinant PaAMP
(rPaAMP) and its mutant proteins against F. solani
Proteins IC50 (lM) Relative activity
rPaAMP 1.36 100
PaAMP 1.30 104
N6R 2.57 53
K5A 2.72 50
K36E 1.90 71
R38A 1.91 70
F25A 6.96 19
I27A 4.90 28
V34A 7.21 18
I27A–V34A 17.68 7
GFP–AMP 2.31 60
AMP–GFP 2.20 67
GFP >50
Thioredoxin >50
Each IC50 value was determined as an average of three independent
measurements as described in Fig. 2 and the relative activity is deﬁned
in Section 2.
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fusion protein was required for both the interaction and the
inhibition of fungal spores. The GFP–PaAMP fusion protein
was also inhibitory to the growth of fungal hyphae. In the
presence of GFP–PaAMP, the tips of fungal hyphae ﬁrst
showed ballooning (Fig. 3C1) and were green ﬂuorescent
(Fig. 3C2) before they burst and eventually release of all
protoplasm with only empty walls left (Fig. 3C1). The
fungal cell walls could not be labelled by GFP–PaAMP
(Fig. 3C2), suggesting that they were not the interacting sites
of PaAMP. The fusion protein of GFP–PaAMP with double
mutation of I27A and V34A (GFP–PaAMPI–V) and the
fusion protein GFP–PaAMP with K5A mutation (GFP-
PaAMPK5A) were used for studying the roles of the hydro-
phobic surface and basic patch in interacting with fungal
cells. GFP–PaAMPI–V did not inhibit the growth of the fun-
gus and no labelling of the fungal hyphae by GFP–PaAM-
PI–V could be observed (Fig. 3D). This result strongly
suggests that the hydrophobic surface of PaAMP is required
for the interaction between the fungal membranes and
PaAMP. Similarly, the spore germination of F. solani was
not inhibited by GFP–PaAMPI–V (Fig. 3E1) and the cells
were not labelled by GFP–PaAMPI–V (Fig. 3E2). Although,
PaAMPK5A showed a nearly 50% reduction of its antimicro-
bial activity (Table 1), the GFP–PaAMPK5A protein can la-
bel the membranes of F. solani (Fig. 3F), suggesting that the
basic patch of PaAMP plays a less important role in
PaAMP–membrane interaction.
To further analyse the interaction of PaAMP and fungal
membranes, we isolated sphingolipids from N. crassa and stud-
ied the binding of PaAMP with the lipids. As shown in Fig.
4A, rPaAMP had a dosage-dependent binding to sphingoli-
pids. PaAMPK5Acould also bind to the sphingolipids. How-
ever, its binding eﬃciency was much lower than that of
rPaAMP. PaAMPI–V showed little binding to the sphingoli-Fig. 1. Analyses of recombinant fusion PaAMP and their puriﬁcation
by SDS–PAGE. Panel A, Recombinant PaAMP (rPaAMP) was
overproduced as a fusion protein with the expression vector pET30.
Lane 1 and lane 2, whole cell extracts of E. coli cells containing pET30
and pET30AMP, respectively. Lane 3, rPaAMP puriﬁed with a metal-
chelating column. Lane 4, rPaAMP after removal of the N-terminal
fusion portion of the fusion protein. Panel B, puriﬁed GFP–AMP (lane
1) and AMP–GFP (lane 2) fusion proteins. The molecular mass
markers are shown in the left side of the gels.pids, conﬁrming that the hydrophobic surface is critical to
the interaction of PaAMP and the fungal lipids. The binding of
PaAMP to sphingolipids was dependent upon the concentrationFig. 2. Determination of values of IC50 of rPaAMP and its mutant
derivatives. Recombinant PaAMP and mutant PaAMP proteins were
ﬁrst diluted in 2-fold series before they were mixed with the spore
suspension of F. solani (A) or N. crassa (B). The growth of the spores
were measured by monitoring the optical density at 595 nm after 24 h
incubation at 25 C in YPG medium. The values of optical density
were plotted as functions of protein concentration (lM) in semilog
plot. The eﬀects of the following proteins were shown: GFP (––––);
thioredoxin (––m––); PaAMP (––s––); rPaAMP (––h––); GFP–AMP
(––D––); rPaAMPK5A (––n––); rPaAMPI26A–V34A (- - -m- - -).
Fig. 3. Interaction of GFP–PaAMP fusion protein with the fungus F. solani observed with bright ﬁeld microscopy (A1 through F1) or ﬂuorescence
microscopy (A2 through F2). (A) Incubation of the fungal spores with GFP–PaAMP inhibited their germination. The release of some protoplasm
could be labelled by GFP–PaAMP fusion protein. (B) Spore germination in the presence of GFP. (C) Empty cell wall (CW) and ballooning of the
hypha tip, which is green ﬂuorescent, in the presence of GFP–PaAMP. (D) No inhibition of the growth of the fungal hyphae by GFP. The hypha
protoplasm is not green ﬂuorescent. (E) Germination of the spores in the presence of GFP–PaAMPI26A–V34A. (F) Labelling of the fungus by GFP–
PaAMPK5A as demonstrated by green ﬂuorescent hyphae.
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130 pmol coated sphingolipids gave the highest binding of
PaAMP. Ergosterol, which forms lipid raft with sphingolipids
[20], enhanced the binding of PaAMP to sphingolipids (Fig.
4C), suggesting that lipid raft could be the site of PaAMP–
membrane interaction. PaAMP did not bind ergosterol if the
sphingolipids were not present (data not shown).4. Discussion
The amphipathic feature of PaAMP is shared by many anti-
microbial peptides and proteins and it plays an important role
in antimicrobial activity [21]. In the present study, we show that
overproduction of active PaAMP in E. coli can be obtained
since the IC50 values for native and recombinant PaAMP on
F. solani are nearly identical. Furthermore, the results based
on site-speciﬁc mutagenesis of PaAMP show that the positive
patch and the hydrophobic surface are both important for
the antifungal function of PaAMP.Mutations in the hydropho-
bic surface, however, have a more profound eﬀect on bothantifungal activity and membrane-interacting properties.
Mutations in the hydrophobic surface of PaAMP led to an
inability of mutant PaAMP to interact with fungal plasma
membranes while mutations in the positive patch did not dis-
rupt the protein–membrane interaction (Fig. 3). The expression
system used in this study is also suited for the overproduction of
active GFP–PaAMP fusion proteins. The inhibition of fungal
growth by both GFP–PaAMP and PaAMP–GFP (Table 1)
suggests that PaAMP is folded as an independent structural
domain in fusion proteins.
Since PaAMP is inhibitory to certain fungal species while
no inhibitory eﬀect of PaAMP is observed against plant cells,
animal cells [5] and yeast species (Saccharomyces cerevisiae
and Pichia pastoris, Peng and Zhao, unpublished data), the
interaction of PaAMP and cell membranes must be speciﬁc
[9]. Our results show that PaAMP interacts with sphingoli-
pids from N. crassa and the interaction required the hydro-
phobic surface of PaAMP (Fig. 4). The binding of PaAMP
to the sphingolipids is enhanced by ergosterol that forms
lipid raft with sphingolipids [20], suggesting that lipid raft
could be PaAMPs binding site as in case of DmAMP
Fig. 4. Binding of PaAMP with sphingolipids from N. crassa. (A)
Dosage-dependent binding of PaAMP proteins to the sphingolipids
isolated from N. crassa. To each well of a microtiter plate coated
with 130 pmol sphingolipids, PaAMP (circles), PaAMPK5A (squares)
and PaAMPI–V at the concentrations indicated were added and the
binding was determined with ELISA. (B) The dosage–response curve
of the binding of PaAMP to sphingolipids. To wells of a microtiter
plate coated with diﬀerent amount of sphingolipids, 1.5 lM PaAMP
was added and the binding was determined with ELISA. (C)
Enhancement of PAMP binding to sphingolipids by ergosterol.
Diﬀerent amount of ergosterol was coated to the wells that
contained 130 pmol sphingolipids and the binding of PaAMP was
determined as in panel B. Data represent an average of triplicate
measurements.
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gal membranes (Fig. 3), but it led to a reduced sphingolipid
binding eﬃciency (Fig. 4). We speculate that mutations in the
positive patch could lead to a reduced speciﬁcity of PaAMP–
membrane lipid interaction, resulting in a decrease of antimi-
crobial activity.
Our results suggest that the antimicrobial mechanism of
PaAMP is similar to that of DmAMP from D. merckii, which
has been shown to interact with yeast sphingolipids [8–10],
even though the structures of these two proteins are diﬀerent.
DmAMP is predicted to have a same structure of RaAFP2 [2]
that is comprised of a babb fold stabilized by 4 disulﬁde bonds
while PaAMP contains a cysteine-knot fold [5,12]. Furtherstudy is needed to know the exact nature of the fungal sphin-
golipids that speciﬁcally interact with PaAMP.Acknowledgements: This study is supported by a grant from NSFC
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